Last reviewed · How we verify
adapalene lotion 0.1%
Adapalene is a topical retinoid that works by binding to retinoic acid receptors, modulating gene expression and promoting cell turnover.
Adapalene is a topical retinoid that works by binding to retinoic acid receptors, modulating gene expression and promoting cell turnover. Used for Acne vulgaris, Aging skin.
At a glance
| Generic name | adapalene lotion 0.1% |
|---|---|
| Also known as | Differin Lotion 0.1%, Differin® Lotion 0.1% |
| Sponsor | Galderma R&D |
| Drug class | Retinoid |
| Target | Retinoic acid receptor |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
This leads to increased cell turnover, reduced comedogenesis, and improved skin appearance. Adapalene's mechanism is similar to other retinoids, but its unique formulation allows for better penetration and reduced irritation.
Approved indications
- Acne vulgaris
- Aging skin
Common side effects
- Skin irritation
- Dryness
- Redness
Key clinical trials
- Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin (PHASE1)
- Tolerability Comparison of Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin (PHASE1)
- Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1% (PHASE3)
- Comparison of Four Different Regimens of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in Acne Vulgaris (PHASE3)
- Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1% (PHASE3)
- Adjunctive Usage of a Moisturizing Lotion (Cetaphil® Moisturizing Lotion) to Limit the Skin Irritation Linked to the Set-Up of a Treatment by Topical Retinoid (Differin® Gel 0,1%) in Healthy Subjects of Chinese Origins (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- adapalene lotion 0.1% CI brief — competitive landscape report
- adapalene lotion 0.1% updates RSS · CI watch RSS
- Galderma R&D portfolio CI